![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PDI, INC. SAYS GLAXOSMITHKLINE ENDS DRUG SALES CONTRACT
PDI, INC. SAYS GLAXOSMITHKLINE ENDS DRUG SALES CONTRACT
PDI, Inc. a contract sales and marketing services provider to the biopharmaceutical industry, today announced that it has received verbal notification from GlaxoSmithKline (GSK) of its intention not to renew its contract sales engagement with PDI for 2007. The contract, which represents approximately $65 million to $70 million in revenue on an annual basis, will expire as scheduled on December 31, 2006.
BioSpace (http://www.biospace.com/news_story.aspx?StoryID=31101&full=1)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct